Navigation Links
Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Date:8/25/2009

reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of Aug. 25, 2009 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
2. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
3. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
6. Medarex to Receive Milestone Payment from Amgen
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
10. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
11. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Orthopedic Soft Tissue Repair ... About Orthopedic Soft Tissue ... of cells that connect, support, or surround bones. ... such as tendons, ligaments, cartilage, fascia, and other ...
(Date:8/27/2014)...  Decision Resources Group finds that physicians surveyed ... gastroenterology, endocrinology and nephrology) expect the robustness and ... been assessed in to be the strongest influencers ... Other key findings from the ... of Biosimilars Across Physician Specialties : ...
(Date:8/27/2014)... Mass. , Aug. 27, 2014 Decision ... that characterized the Memphis health ... way to clinical integration, with rivals Methodist Le Bonheur ... respective physician groups to coordinate patient care. In addition, ... which has the most health plan enrollment in the ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... 2011 Centre Partners Management LLC ("Centre Partners"), a leading ... and Los Angeles, today announced the completion of the sale ... Troy Limited (Nasdaq: HELE). Kaz is an international leader in ... valued at $260 million subject to certain closing working capital ...
... The MED Group, a Managed Health Care Associates, Inc. ...  The website was created to help answer questions for ... about competitive bidding and how patients can receive their ... Centers for Medicare and Medicaid Services (CMS) will be ...
Cached Medicine Technology:Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 2Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 3New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 2New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 3
(Date:8/27/2014)... 2014 The American College ... the management and treatment of pulmonary arterial hypertension ... Hypertension in Adults: CHEST Guideline, in the journal ... clinicians, and provide the latest and most accurate ... Hypertension Association (PHA) – the country’s leading ...
(Date:8/27/2014)... use of hormone therapy has spawned a prevalent but ... with hot flashes, according to a study by a ... In the study published in the Aug. 27 online ... found that moderate to severe hot flashes also ... most women. Women with VMS experience more than feeling ...
(Date:8/27/2014)... August 27, 2014 Ticket Down ... tickets at Levi’s Stadium in Santa Clara. Levi’s ... Clara, California just opened in July and will host their ... takes on Chile. These are two of the best teams ... World Cup and will look to continue their successes from ...
(Date:8/27/2014)... Sound Telecom, a leading telecommunications company that ... communication systems, has unveiled an article titled “ Three ... Messaging .” The piece examines the world of medical ... remain compliant with HIPAA and HITECH requirements. , ... at Sound Telecom, opens with evidence that the use ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 Parker ... protecting the rights of victims injured by defective medical ... in place for discovery procedures, specifically Collection and Preservation ... C.R. Bard’s transvaginal mesh devices. (MDL No. 2187, In ... Litigation, the United States District Court, Southern District or ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4
... Find a Top Doc ... in their community. , ... (PRWEB) November 16, 2009 -- If one wnats to find love, no problem, they just jump ... match. Want to find a great doctor, now that,s another story. For some reason ...
... PharmaShack.com - ... off on all items, and a new and exciting range of new dietary products such ... ... nowadays, some are planning to go on a diet, others have high cholesterol counts, men ...
... ... available in Istanbul Hospitals. Both eyes iLASIK treatment packages including flight tickets and accommodations ... ... announce the iLASIK procedure is now available in Istanbul Hospitals. Both eyes iLASIK treatment ...
... ... Laser Institute announced today that Dr. Jon Dishler has been selected by ... United States for 2009. The list of leading Laser Eye Surgeons of ... Forbes Magazine.,Internationally recognized, leader of numerous FDA laser vision trials, and originator ...
... , NANJING, China, Nov. 16 /PRNewswire-Asia/ ... ), a leading pharmaceutical company,specializing in the development, manufacturing, and marketing ... for the quarter ended September 30, 2009. , , ... (US$65.0 million) for the third, ...
... A study of 145 preschool children reports, for the ... phthalates in mothers, prenatal urine are elevated their sons ... games, such as trucks and play fighting. The ... the International Journal of Andrology . Because ...
Cached Medicine News:Health News:PharmaShack.com Embraces Fall - Offers 15 Percent Off of All Meds on Site 2Health News:iLASIK Treatment Now Available in Istanbul, Turkey at World Eye Hospitals 2Health News:iLASIK Treatment Now Available in Istanbul, Turkey at World Eye Hospitals 3Health News:iLASIK Treatment Now Available in Istanbul, Turkey at World Eye Hospitals 4Health News:Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine 2Health News:Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine 3Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 12Health News:Pilot study relates phthalate exposure to less-masculine play by boys 2Health News:Pilot study relates phthalate exposure to less-masculine play by boys 3
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
... and the Penilab V have an exceptionally sensitive plethysmograph ... similar to the Model 1061 shown below, but does ... later. The Penilab V has a Doppler. ... you'll need to get started. Latex rubber cuffs ...
... Model 246 is designed for vascular ... graphic recorders. Its primary use ... studies using a cuff with air. ... using two cuffs - a proximal ...
... SP MRI-Compatible Anesthesia System is perfect for larger ... one type of anesthetic agent. , ,The ... to its wider stance, has a larger work ... assembly is utilized in both the Integra I ...
Medicine Products: